Unlock instant, AI-driven research and patent intelligence for your innovation.

Aspirin hapten, aspirin complete antigen, aspirin antibody, preparation method and application

An aspirin, complete antigen technology, applied in the field of antibody and preparation, aspirin hapten, complete antigen, can solve the problem of lack of high-throughput, simple and rapid detection methods, etc.

Active Publication Date: 2022-08-09
GENERAL HOSPITAL OF PLA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Lack of high-throughput, simple and rapid detection methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aspirin hapten, aspirin complete antigen, aspirin antibody, preparation method and application
  • Aspirin hapten, aspirin complete antigen, aspirin antibody, preparation method and application
  • Aspirin hapten, aspirin complete antigen, aspirin antibody, preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0035] The present invention provides the preparation method of the aspirin hapten derivative described in the above technical scheme, comprising the following steps:

[0036] The salicylic acid, 5-bromovaleryl chloride and Lewis acid catalyst are mixed (hereinafter referred to as the first mixture) to undergo an acylation reaction to obtain the aspirin hapten derivative of the structure described in formula 1.

[0037] In the present invention, unless otherwise specified, the raw materials used are all commercially available products well known to those skilled in the art.

[0038] In the present invention, the Lewis acid catalyst is preferably anhydrous aluminum trichloride.

[0039] In the present invention, the mass ratio of the salicylic acid and 5-bromovaleryl chloride is preferably 6.9:20.

[0040] In the present invention, the mass ratio of the salicylic acid and the Lewis acid catalyst is preferably 6.9:0.5.

[0041] In the present invention, the first mixing sequen...

Embodiment 1

[0135] according to figure 1 In the reaction equation shown, 6.9 g of salicylic acid (compound 1), 20.0 g of 5-bromovaleryl chloride (compound 2), and 0.5 g of anhydrous aluminum trichloride were added to a 50 mL three-necked flask. The temperature was raised to 60-65 °C, and the reaction was kept stirring for 1 h. TLC monitored the completion of the reaction and cooled the temperature to 30-35 °C, slowly added 30 mL of deionized water, controlled the temperature to 0-10 °C for crystallization for 1 h, and filtered to obtain 11.24 g of compound 3 crude product.

[0136] Add 11.0 g of compound 3 to 40 mL of ethanol in a 50 mL three-necked flask, heat up to 50 °C for dissolving for 30 min, filter, cool the filtrate to 0-5 °C for 2 h, filter, and vacuum dry to obtain 10.05 g of compound 3 in a yield of 67.1%. The HNMR spectrum of the aspirin hapten derivatives prepared in this example is as follows: image 3 shown.

Embodiment 2

[0138] Take 10 mg of the aspirin hapten derivative prepared in Example 1, add 1 mL of DMSO to dissolve completely, and obtain an aspirin hapten derivative solution;

[0139] Dissolve 20 mg of bovine thyroglobulin in 5 mL, 0.1 mol / L sodium bicarbonate solution to obtain a bovine thyroglobulin solution;

[0140] Mix the aspirin hapten derivative solution and bovine thyroglobulin solution, stir at room temperature for 2 hours to obtain the coupling reaction solution, dialyze the coupling reaction solution with PBS buffer solution for 4 times to obtain the aspirin complete antigen, which is frozen at -20 ℃ save.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of drug monitoring, and particularly relates to an aspirin hapten, a complete antigen, an antibody, a preparation method and application. The invention provides an aspirin hapten derivative. The aspirin hapten derivative has a structure as shown in a formula 1. A derivative site of the aspirin hapten derivative provided by the invention is located on an acetyl structure of aspirin, and the structural region is a non-common characteristic structure of aspirin and an active metabolite salicylic acid. The non-common characteristic structure is shielded by carrier protein, so that an antibody prepared from an aspirin complete antigen obtained from the aspirin hapten derivative provided by the invention has the capability of equivalently recognizing aspirin and an active metabolite salicylic acid with high sensitivity.

Description

technical field [0001] The invention belongs to the technical field of drug monitoring, and in particular relates to aspirin haptens, complete antigens, antibodies, and preparation methods and applications. Background technique [0002] Aspirin (2-(acetoxy) benzoic acid, also known as acetylsalicylic acid) has been used for a hundred years until 2015 and has become one of the three classic drugs in the history of medicine. To this day, aspirin is still the most widely used antipyretic, analgesic and anti-inflammatory drug in the world, and it is also used as a standard preparation for comparing and evaluating other drugs. [0003] Aspirin has an antithrombotic effect in the body, can inhibit the release and aggregation of platelets, and is clinically used to prevent the onset of cardiovascular and cerebrovascular diseases. However, it is clinically found that patients who take regular doses of aspirin enteric-coated tablets (300 mg / d loading dose, 100 mg / d maintenance dose)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C69/63C07C67/14C07K14/47C07K14/765C07K14/77C07K14/795C07K16/44G01N33/53G01N33/543G01N33/58C07K1/107
CPCC07C69/63C07C67/14C07K14/765C07K14/77C07K14/795C07K14/4717C07K16/44G01N33/5308G01N33/54326G01N33/581C07K2317/56C07K2317/92
Inventor 张春燕田亚平崔佳奕史文杰程昱璇舒杨
Owner GENERAL HOSPITAL OF PLA